相似文献
1
Covid-19 vaccination among people with disability-Statement from the iADH scientific committee.
Spec Care Dentist. 2021 Nov;41(6):655-657. doi: 10.1111/scd.12667. Epub 2021 Oct 15.
2
Making COVID-19 vaccinations accessible for people with disabilities.
Vaccine. 2021 Sep 24;39(40):5727-5728. doi: 10.1016/j.vaccine.2021.08.062. Epub 2021 Aug 24.
3
Vaccine hesitancy among working-age adults with/without disability in the UK.
Public Health. 2021 Nov;200:106-108. doi: 10.1016/j.puhe.2021.09.019. Epub 2021 Oct 27.
4
[Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
Rev Chilena Infectol. 2021 Apr;38(2):185-188. doi: 10.4067/S0716-10182021000200185.
5
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
6
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
Intern Med J. 2021 Jun;51(6):955-959. doi: 10.1111/imj.15339.
7
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
8
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
9
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome.
Front Public Health. 2021 Aug 12;9:704520. doi: 10.3389/fpubh.2021.704520. eCollection 2021.
10
Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination.
J Med Virol. 2021 Dec;93(12):6474. doi: 10.1002/jmv.27263. Epub 2021 Aug 12.
引用本文的文献
1
COVID-19 vaccine hesitancy and attitudes of subjects with disability and their carers in Saudi Arabia: a cross-sectional study.
Front Public Health. 2024 Feb 28;12:1282581. doi: 10.3389/fpubh.2024.1282581. eCollection 2024.
本文引用的文献
1
Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis.
Vaccines (Basel). 2021 Jun 1;9(6):582. doi: 10.3390/vaccines9060582.
2
[Consensus of the Genetics Branch of the Chilean Society of Pediatrics on the prioritization of people with Down syndrome and rare diseases for vaccination against SARS-CoV-2].
Andes Pediatr. 2021 Apr;92(2):309-315. doi: 10.32641/andespediatr.v92i2.3716.
3
Coronavirus disease 2019 vaccination in transplant recipients.
Curr Opin Infect Dis. 2021 Aug 1;34(4):275-287. doi: 10.1097/QCO.0000000000000739.
4
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Vaccines (Basel). 2021 May 6;9(5):467. doi: 10.3390/vaccines9050467.
5
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Int J Rheum Dis. 2021 Jun;24(6):746-757. doi: 10.1111/1756-185X.14107. Epub 2021 May 10.
6
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
7
Should people with severe mental illness be prioritized for the COVID-19 vaccination?
Int J Biol Sci. 2021 Apr 10;17(6):1443-1445. doi: 10.7150/ijbs.57750. eCollection 2021.
8
Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.
Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4091-4099. doi: 10.1007/s00405-021-06794-6. Epub 2021 Apr 15.
9
Efficacy and safety of COVID-19 vaccines: a systematic review.
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Mar;23(3):221-228. doi: 10.7499/j.issn.1008-8830.2101133.
10
Covid-19: GPs opt to prioritise all patients with learning disabilities for vaccination.
BMJ. 2021 Feb 19;372:n510. doi: 10.1136/bmj.n510.
Zotero 插件